Sanofi’s “Sun rising” approach to FDA for Acomplia (rimonabant) approval
New mystery that is going to happen with the diet drug developer Sanofi-Aventis is that the Acomplia (rimonabant) diet drug developer is going to update the old talking process with FDA for Acomplia approval. Millions of American’s belonging to obese community waiting for the Acomplia approval in their country, U.S. No doubt approval moment of Acomplia by Food and Drug Administration (FDA) will be the wondering moment for them. Read
More...
Ambiguous response from Sanofi's UK support site
Sanofi's report in UK support website for diet
pill Acomplia (rimonabant) regarding the drug either helps to quit
smoking or not, making some disgusting response to the resident
of US and European regulators. Read
More...
New website support for acomplia users in UK by sanofi
The Acomplia diet drug developer, Sanofi-Aventis
has commenced a support program related to weight loss in Britain.
Under this program information on weight loss is available. Accessing
the weight loss advices on this website will not be easy. Read
More...
Acomplia - A combatant of Breast Cancer
Italian researchers presented another curious research
for Acomplia. According to them Acomplia also play a major role
in reducing breast cancer. According to Maurizio Bifulco of the
Università degli Studi di Salerno, research escorted, Acomplia
"inhibited human breast cancer cell proliferation" in
both gnawer and test tube studies. Read
More...
